Recombinant Human MIP-3 beta (CCL19)
Catalog No : IGX-RP507
0.00€
0.00€
Shipping cost plus VAT not included , delivery in 7-14 business days
| Product name | Recombinant Human MIP-3 beta (CCL19) | ||
|---|---|---|---|
| Catalog No | IGX-RP507 | ||
| Supplier’s Catalog No | IGX-RP507 | ||
| Supplier | ImuGeX | ||
| Source antigen | E. coli | ||
| Reactivity | Human | ||
| Cross reactivity | |||
| Applications | |||
| Molecular weight | 9.1 | ||
| Storage | -70°C | ||
|---|---|---|---|
| Other names | MIP-3-beta, C-C motif chemokine 19, Beta-chemokine exodus-3, CK beta-11, Epstein-Barr virus-induced molecule 1 ligand chemokine, EBI1 ligand chemokine, ELC, Small-inducible cytokine A19, Exodus-3, MIP3<br/>Recombinant Human Macrophage Inflammatory Protein-3 Beta (CCL19) | ||
| Grade | Highly Purified | ||
| Purity | >95% as determined by SDS-PAGE | ||
| Form | Lyophilized from a 0.2 μm filtered solution in Acetonitrile and TFA with BSA as a carrier protein | ||
| Reactivity life | 6 months | ||
| Note | For reserch purpose only | ||
| Purity | >95% as determined by SDS-PAGE | ||
| Description | CCL19 is a chemokine that belongs to the CC family of growth factors and signals through the CCR7 receptor. CCl19 has been shown to be expressed in the thymus, lymph nodes and in activated bone marrow stromal cells. When anti-inflammatory signals are released, expression of CCL19 gets down-regulated – specifically by IL-10. | ||
Product Details
© 2020 Imugex All Rights Reserved